HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ghada Abdelhamid Selected Research

Hydroxyeicosatetraenoic Acids (HETE)

1/2018The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
5/2017The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol.
3/2016CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism.
12/201519-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy.
10/2015Development of cellular hypertrophy by 8-hydroxyeicosatetraenoic acid in the human ventricular cardiomyocyte, RL-14 cell line, is implicated by MAPK and NF-κB.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ghada Abdelhamid Research Topics

Disease

7Cardiomegaly (Heart Hypertrophy)
07/2017 - 04/2013
4Hypertrophy
12/2015 - 05/2013
3Hepatocellular Carcinoma (Hepatoma)
11/2013 - 09/2010
2Body Weight (Weight, Body)
01/2022 - 04/2013
2Cardiotoxicity
01/2018 - 03/2016
2Cardiovascular Diseases (Cardiovascular Disease)
10/2015 - 04/2013
1Urinary Bladder Neoplasms (Bladder Cancer)
03/2022
1Neoplasms (Cancer)
03/2022
1Brain Edema (Cerebral Edema)
01/2022
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2018
1Myocardial Infarction
05/2015
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
05/2015
1Heart Failure
05/2015

Drug/Important Bio-Agent (IBA)

5Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2018 - 10/2010
5Hydroxyeicosatetraenoic Acids (HETE)IBA
01/2018 - 10/2015
5Epoxide HydrolasesIBA
01/2018 - 04/2013
4AcidsIBA
01/2018 - 10/2015
4EnzymesIBA
01/2018 - 04/2013
3Isoproterenol (Isoprenaline)FDA LinkGeneric
05/2017 - 04/2013
3VanadiumIBA
11/2013 - 09/2010
2Arachidonic Acid (Vitamin F)IBA
01/2018 - 07/2017
2Angiotensin IIIBA
07/2017 - 12/2015
2Mitogen-Activated Protein KinasesIBA
05/2017 - 03/2016
2Cytochrome P-450 CYP1A1 (CYP1A1)IBA
11/2013 - 10/2010
2CytochromesIBA
05/2013 - 04/2013
2ammonium metavanadateIBA
10/2010 - 09/2010
1Propolis (Bee Bread)IBA
03/2022
1Caspase 3 (Caspase-3)IBA
03/2022
1QuercetinIBA
01/2022
12-MethoxyestradiolIBA
01/2018
1Daunorubicin (Cerubidine)FDA LinkGeneric
01/2018
1AnthracyclinesIBA
01/2018
12,4,3',5'-tetramethoxystilbeneIBA
07/2017
1Superoxides (Superoxide)IBA
05/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2016
1Isoniazid (Ftivazide)FDA LinkGeneric
12/2015
119-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
12/2015
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
12/2015
1Atrial Natriuretic Factor (ANF)IBA
10/2015
18-hydroxyeicosatetraenoic acidIBA
10/2015
1Glutathione (Reduced Glutathione)IBA
05/2015
1Buthionine SulfoximineIBA
05/2015
1Proteins (Proteins, Gene)FDA Link
11/2013
1Polychlorinated Dibenzodioxins (TCDD)IBA
11/2013
1Messenger RNA (mRNA)IBA
11/2013
120-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
05/2013
114,15-epoxy-5,8,11-eicosatrienoic acidIBA
05/2013
1thiouredopyrenetrisulfonateIBA
04/2013
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
10/2010
1NAD (NADH)IBA
09/2010
1Oxidoreductases (Dehydrogenase)IBA
09/2010
1quinone (benzoquinone)IBA
09/2010

Therapy/Procedure

1Aftercare (After-Treatment)
01/2022